Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Adult hypophosphatasia (HPP) is a rare, inherited metabolic bone disease caused by low alkaline phosphatase activity, and the adult outlook matters because symptoms often appear gradually as recurring stress fractures, foot and thigh pain, early tooth loss, muscle weakness, or joint discomfort that mimics osteoporosis or arthritis. Misdiagnosis is common, which delays access to enzyme replacement therapy and can lead to treatments like bisphosphonates that may worsen the condition. Prognosis in adults is generally more favorable than in infants, with most people maintaining a normal lifespan, though quality of life depends on fracture frequency, pain control, dental care, and mobility support. Because presentation varies widely between individuals, tracking your specific pattern of symptoms is essential for accurate diagnosis and safe treatment planning. There are several important factors to consider, including red flags and next steps, so see below to understand more.
If unexplained bone pain, repeated fractures, or unusual dental problems have you searching for answers, a free, instant online symptom check can help you organize what you are experiencing into clear, shareable information. Rare conditions like adult HPP are frequently missed because their signs overlap with common bone and joint disorders, so arriving at your appointment with a documented symptom timeline makes it easier for your clinician to consider the right tests, such as alkaline phosphatase levels. It takes only a few minutes, requires no personal cost, and gives you a more confident starting point for your next conversation about care.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) is a rare inherited disorder caused by mutations in the ALPL gene, leading to low activity of the enzyme alkaline phosphatase (ALP). While many people know HPP as a childhood disease, adult-onset HPP is more common than previously thought—and understanding your adultoutlook can make all the difference in managing symptoms, preventing complications, and planning for the future.
Variable Symptoms and Timing
Impact on Quality of Life
Risk of Misdiagnosis
Progressive Nature
Detailed Medical History
Laboratory Tests
Genetic Testing
Imaging Studies
Once adult HPP is confirmed, a personalized management plan is essential. Your adultoutlook depends on early, appropriate intervention.
Enzyme Replacement Therapy (ERT)
Pain Management
Physical Therapy & Exercise
Dental Care
Nutritional Support
Lifestyle Modifications
Genetic Counseling
Ongoing Monitoring
Staying in tune with your body helps you and your healthcare team adapt your adultoutlook plan:
• Keep a daily log of pain levels, mobility, fracture incidents and dental issues.
• Note triggers for flare-ups—changes in activity, diet or stress.
• Use symptom trackers or health apps to share data with your doctor.
If you’re unsure whether your symptoms might point to adult HPP—or if new or worsening issues arise—you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you identify potential concerns and gather useful information before your next appointment. Try it now.
While HPP symptoms often develop gradually, certain signs warrant immediate medical attention:
• Acute fracture with severe pain, swelling or deformity
• Sudden chest pain or shortness of breath (possible rib fractures or pulmonary issues)
• Neurological changes like muscle weakness or numbness
• Severe dehydration or kidney problems (from high calcium levels)
Always speak to a doctor about anything that could be life threatening or serious.
Living with a rare disease can feel isolating. Connecting with others and trusted professionals can improve your adultoutlook:
• Patient support groups (online or local) for sharing experiences
• Rare disease foundations offering educational resources
• Mental health professionals for coping strategies
• Multidisciplinary medical team: endocrinologist, geneticist, rheumatologist, dentist, physical therapist
Research in HPP is ongoing. New therapies, clinical trials and supportive care guidelines continue to evolve. To stay up to date:
• Follow reputable organizations (e.g., Rare Bone Disease Alliance, ClinicalTrials.gov).
• Discuss emerging treatments and trials with your specialist.
• Subscribe to newsletters from bone health or genetic counseling groups.
Your adultoutlook with hypophosphatasia doesn’t have to be defined by pain, fractures or uncertainty. With timely diagnosis, appropriate therapy and a supportive care plan, many adults lead active, fulfilling lives. Remember:
If you’re experiencing symptoms that concern you, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. And always speak to a doctor about anything that could be life threatening or serious. By taking proactive steps now, you can shape a brighter, healthier adultoutlook with HPP.
(References)
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Wang Z, Liu T, Su Q, Luo H, Lou L, Zhao L, Kang X, Pan Y, Nie Y. Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta-Analysis. Pharmacoepidemiol Drug Saf. 2024 Aug;33(8):e5880. doi: 10.1002/pds.5880. PMID: 39135518.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Reicher L, Shilo S, Godneva A, Lutsker G, Zahavi L, Shoer S, Krongauz D, Rein M, Kohn S, Segev T, Schlesinger Y, Barak D, Levine Z, Keshet A, Shaulitch R, Lotan-Pompan M, Elkan M, Talmor-Barkan Y, Aviv Y, Dadiani M, Tsodyks Y, Gal-Yam EN, Leibovitzh H, Werner L, Tzadok R, Maharshak N, Koga S, Glick-Gorman Y, Stossel C, Raitses-Gurevich M, Golan T, Dhir R, Reisner Y, Weinberger A, Rossman H, Song L, Xing EP, Segal E. Deep phenotyping of health-disease continuum in the Human Phenotype Project. Nat Med. 2025 Sep;31(9):3191-3203. doi: 10.1038/s41591-025-03790-9. Epub 2025 Jul 15. PMID: 40665053.
* Magagnoli J, Knopf K, Hrushesky WJ, Carson KR, Bennett CL. Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic Review. Am J Hematol. 2025 May;100(5):840-846. doi: 10.1002/ajh.27598. Epub 2025 Feb 11. PMID: 39935027; PMCID: PMC11966349.
* Inoue M. [Hypophosphatasia]. Nihon Rinsho. 2006 Jun 28;Suppl 2:104-7. PMID: 16817361.
* Kishnani PS, Seefried L, Ozono K, Martos-Moreno GÁ, Rockman-Greenberg C, Fowler D, Burke LK, Mowrey WR, Rush ET, Ebeling PR, Högler W, Linglart A, Fang S, Petryk A, Dahir KM. The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data. Orphanet J Rare Dis. 2025 Nov 24;20(1):626. doi: 10.1186/s13023-025-04129-w. Epub 2025 Nov 24. PMID: 41286962; PMCID: PMC12751868.
* Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007 Oct 4;2:40. doi: 10.1186/1750-1172-2-40. Epub 2007 Oct 4. PMID: 17916236; PMCID: PMC2164941.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.